Carna Biosciences, Inc. Logo

Carna Biosciences, Inc.

Clinical-stage biopharma developing small molecule kinase inhibitors.

4572 | T

Overview

Corporate Details

ISIN(s):
JP3220550002
LEI:
Country:
Japan
Address:
神戸市中央区港島南町一丁目5番5号

Description

Carna Biosciences, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of small molecule kinase inhibitors. The company focuses on creating therapies for diseases with significant unmet medical needs, particularly in oncology and autoimmune disorders. Carna Biosciences operates through two core segments: a drug discovery business that advances its proprietary pipeline of drug candidates, and a drug discovery support business. The support division provides the global research community with a comprehensive portfolio of products and services, including a wide array of kinase proteins, biochemical and cell-based screening, and profiling services to accelerate pharmaceutical research and development.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-11-11 07:45
訂正有価証券届出書(組込方式)
Japanese ZIP 347.4 KB
2025-09-12 08:46
訂正有価証券届出書(組込方式)
Japanese ZIP 325.6 KB
2025-08-07 02:46
訂正有価証券届出書(組込方式)
Japanese ZIP 243.9 KB
2025-08-07 02:45
訂正有価証券届出書(組込方式)
Japanese ZIP 244.0 KB
2025-08-07 02:43
確認書
Japanese ZIP 8.8 KB
2025-08-07 02:42
半期報告書-第23期(2025/01/01-2025/12/31)
Japanese ZIP 358.3 KB
2025-07-11 08:47
有価証券届出書(組込方式)
Japanese ZIP 393.6 KB
2025-07-11 08:46
有価証券届出書(組込方式)
Japanese ZIP 393.6 KB
2025-07-11 08:45
有価証券届出書(組込方式)
Japanese ZIP 392.8 KB
2025-03-28 02:41
臨時報告書
Japanese ZIP 28.5 KB
2025-03-26 02:11
内部統制報告書-第22期(2024/01/01-2024/12/31)
Japanese ZIP 24.5 KB
2025-03-26 02:10
確認書
Japanese ZIP 8.7 KB
2025-03-26 02:08
有価証券報告書-第22期(2024/01/01-2024/12/31)
Japanese ZIP 1.3 MB
2024-09-25 08:39
臨時報告書
Japanese ZIP 122.5 KB
2024-08-08 02:51
確認書
Japanese ZIP 8.7 KB

Automate Your Workflow. Get a real-time feed of all Carna Biosciences, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Carna Biosciences, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Carna Biosciences, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Clearmind Medicine Inc. Logo
Clinical-stage psychedelic pharma firm developing treatments for Alcohol Use Disorder.
United States of America
CMND
Clearside Biomedical, Inc. Logo
Biopharmaceutical firm with an FDA-approved microinjector for back-of-the-eye delivery.
United States of America
CLSD
Clene Inc. Logo
A clinical-stage biopharma developing nanotherapeutics for neurodegenerative diseases.
United States of America
CLNN
CMG Pharmaceutical Co., Ltd. Logo
A pharmaceutical firm specializing in Oral Thin Film drug delivery technology.
South Korea
058820
CNS Pharmaceuticals, Inc. Logo
Develops anti-cancer drug candidates for cancers of the brain and nervous system.
United States of America
CNSP
Cocrystal Pharma, Inc. Logo
Clinical-stage biotech developing antiviral drugs for serious and chronic viral diseases.
United States of America
COCP
Co-Diagnostics, Inc. Logo
A molecular diagnostics company that develops and markets advanced PCR technologies.
United States of America
CODX
co.don AG Logo
Develops autologous cell therapies for regenerative treatment of cartilage defects.
Germany
CNW
Coeptis Therapeutics Holdings, Inc. Logo
Biopharmaceutical company developing cell therapy platforms for cancer and other diseases.
United States of America
COEP
Cogent Biosciences, Inc. Logo
A clinical-stage biotech company developing precision therapies for genetic diseases.
United States of America
COGT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.